Compare Adaptive Biotechnologies Corp (ADPT) vs Infosys Limited (INFY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Adaptive Biotechnologies Corp vs Infosys Limited — how do they compare? Adaptive Biotechnologies Corp trades at $25.5 (market cap $4.04B), while Infosys Limited trades at $12.42 (market cap $50.55B). The key difference: Infosys Limited is far larger — about 12.5× Adaptive Biotechnologies Corp's market cap, and Infosys Limited pays a 4.16% dividend while Adaptive Biotechnologies Corp pays none. Which is the better fit depends on your goals.
| ADPT | INFY | |
|---|---|---|
Market Cap | $4.04B | $50.55B |
Sector | Health | Technology |
52-Week High | $25.45 | $20.22 |
52-Week Low | $12.30 | $10.49 |
Enterprise Value | $4.10B | $48.30B |
Dividend Yield | — | 4.16% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →About Infosys Limited
Infosys is a global leader in next-generation digital services and consulting. It enables clients in more than 50 countries to navigate their digital transformation through AI-powered cloud and data solutions.
Read more on INFY →
